Tolerability & long-term disease control by IGHV mutation status among CLL patients on ibrutinib arm of E1912.
Tait D ShanafeltXin Victoria WangCurtis A HansonElisabeth PaiettaSusan M O'BrienJacqueline Claudia BarrientosDiane F JelinekEsteban BraggioJose F LeisCong ZhangPaul M BarrAmanda F CashenAnthony R MatoAvina K SinghMichael MullaneRichard F LittleHarry P ErbaRichard M StoneMark R LitzowMartin S TallmanNeil E KayPublished in: Blood advances (2024)